DiagnoCure led the industry in the launch of a molecular diagnostic for colorectal cancer staging.  This burgeoning industry required extensive clinician education surrounding the product science, the integration of the technology into everyday workflow and the product benefits.  321 Medical Launch developed a comprehensive launch program built on a solid understanding of the oncologists, pathologists and administrators.  The campaign focused on addressing the uncertainty that medical personnel feel in the staging of CRC, and positioned Previstage as the provider of “The Confidence to Treat”.